BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32979698)

  • 1. The role of surgery for locally recurrent and second recurrent rectal cancer with metastatic disease.
    Tanaka A; Uehara K; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Surg Oncol; 2020 Dec; 35():328-335. PubMed ID: 32979698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 3. Locally recurrent rectal cancer and distant metastases: is there still a chance ofcure?
    van Rees JM; Nordkamp S; Harmsen PW; Rutten H; Burger JWA; Verhoef C
    Eur J Surg Oncol; 2023 Sep; 49(9):106865. PubMed ID: 37002176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
    Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
    Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes following salvage surgery for locally recurrent rectal cancer: A 15-year follow-up study.
    Cyr DP; Zih FS; Wells BJ; Swett-Cosentino J; Burkes RL; Brierley JD; Cummings B; Smith AJ; Swallow CJ
    Eur J Surg Oncol; 2020 Jun; 46(6):1131-1137. PubMed ID: 32224071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of an aggressive approach to resection of locally recurrent rectal cancer.
    Wells BJ; Stotland P; Ko MA; Al-Sukhni W; Wunder J; Ferguson P; Lipa J; Last L; Smith AJ; Swallow CJ
    Ann Surg Oncol; 2007 Feb; 14(2):390-5. PubMed ID: 17063304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent.
    Bird TG; Ngan SY; Chu J; Kroon R; Lynch AC; Heriot AG
    Int J Colorectal Dis; 2018 Apr; 33(4):393-401. PubMed ID: 29468354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Prognosis after Surgery for Locally Recurrent Rectal Cancer: A Retrospective Study.
    Nishimuta M; Hamada K; Sumida Y; Araki M; Wakata K; Kugiyama T; Shibuya A; Hashimoto S; Ozeki K; Morino S; Kiya S; Baba M; Nakamura A
    Asian Pac J Cancer Prev; 2021 May; 22(5):1531-1535. PubMed ID: 34048182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abdominosacral resection: long-term outcome in 86 patients with locally advanced or locally recurrent rectal cancer.
    Bosman SJ; Vermeer TA; Dudink RL; de Hingh IH; Nieuwenhuijzen GA; Rutten HJ
    Eur J Surg Oncol; 2014 Jun; 40(6):699-705. PubMed ID: 24679359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.
    Selvaggi F; Fucini C; Pellino G; Sciaudone G; Maretto I; Mondi I; Bartolini N; Caminati F; Pucciarelli S
    Tech Coloproctol; 2015 Mar; 19(3):135-44. PubMed ID: 25384359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-stage anterior high sacrectomy for locally recurrent rectal cancer.
    Fawaz K; Smith MJ; Moises C; Smith AJ; Yee AJ
    Spine (Phila Pa 1976); 2014 Mar; 39(5):443-52. PubMed ID: 24573075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience.
    Asoglu O; Karanlik H; Muslumanoglu M; Igci A; Emek E; Ozmen V; Kecer M; Parlak M; Kapran Y
    Eur J Surg Oncol; 2007 Dec; 33(10):1199-206. PubMed ID: 17400423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results.
    Sorrentino L; Belli F; Valvo F; Villa S; Guaglio M; Scaramuzza D; Gronchi A; Di Bartolomeo M; Cosimelli M
    Surg Oncol; 2020 Dec; 35():89-96. PubMed ID: 32858390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and prognosis of locally recurrent rectal cancer - A national population-based study.
    Westberg K; Palmer G; Hjern F; Johansson H; Holm T; Martling A
    Eur J Surg Oncol; 2018 Jan; 44(1):100-107. PubMed ID: 29224985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.